These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2696844)

  • 1. Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells.
    Wakeling AE
    J Steroid Biochem; 1989; 34(1-6):183-8. PubMed ID: 2696844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells.
    Wakeling AE; Newboult E; Peters SW
    J Mol Endocrinol; 1989 May; 2(3):225-34. PubMed ID: 2665780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
    Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.
    de Cupis A; Noonan D; Pirani P; Ferrera A; Clerico L; Favoni RE
    Br J Pharmacol; 1995 Nov; 116(5):2391-400. PubMed ID: 8581274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antioestrogens without partial agonist activity.
    Wakeling AE; Bowler J
    J Steroid Biochem; 1988 Oct; 31(4B):645-53. PubMed ID: 3199810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.
    Wiseman LR; Johnson MD; Wakeling AE; Lykkesfeldt AE; May FE; Westley BR
    Eur J Cancer; 1993; 29A(16):2256-64. PubMed ID: 8110496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for a novel pure anti-oestrogen.
    Wakeling AE
    Horm Res; 1989; 32 Suppl 1():257-9; discussion 260. PubMed ID: 2613211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal pure antioestrogens.
    Wakeling AE; Bowler J
    J Endocrinol; 1987 Mar; 112(3):R7-10. PubMed ID: 3559447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells.
    Wiseman LR; Wakeling AE; May FE; Westley BR
    J Steroid Biochem; 1989 Jul; 33(1):1-6. PubMed ID: 2761257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.
    Pink JJ; Jiang SY; Fritsch M; Jordan VC
    Cancer Res; 1995 Jun; 55(12):2583-90. PubMed ID: 7780972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Tonetti DA; Jordan VC
    Br J Cancer; 1998 Jun; 77(11):1812-9. PubMed ID: 9667651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.